Related Experiment Videos
Regulating Innovation: Why the European Union Artificial Intelligence Act Matters for Urologists-Recommendations from
Gregor Duwe1, Thomas Knoll2, Karl-Friedrich Kowalewski3
1Department of Urology and Pediatric Urology, University Medical Center Johannes Gutenberg University, Mainz, Germany.
European Urology
|June 11, 2026
Abstract
None:
The key challenge for artificial intelligence (AI) in urology is no longer technical development alone, but safe translation into regulated clinical use. Urologists should use certified, indication-specific AI systems, avoid informal grey-zone adoption, and demand clinically workable regulatory pathways.
Related Concept Videos
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...